SERCEB is one of eleven Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases funded by the National Institute of Allergy and Infectious Disease (NIAID) to support basic and translational research focused on emerging infections and potential bioterror agents that may threaten the health of our nation. Now in its eighth year, SERCEB is headquartered at the University of North Carolina in Chapel Hill and supports investigators at more than ten institutions across the Southeast (Region IV).
SERCEB is governed by a Steering Committee led by the Director, Dr. Fred Sparling, and made up of representatives from each member institution. The decisions and actions of the Steering Committee are supported by the Scientific Advisory Board (SAB) and our NIAID Program Officers. Read more>>